CorMedix Inc.CRMDNASDAQ
Loading
Year-over-year revenue growth rate
3Y CAGR
-58.9%/yr
vs +62.9%/yr prior
Acceleration
-121.7pp
Decelerating
Percentile
P51
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 23.34% |
| Q3 2025 | 162.41% |
| Q2 2025 | 1.68% |
| Q1 2025 | 25.22% |
| Q4 2024 | 172.43% |
| Q3 2024 | 1321.14% |
| Q2 2024 | 0.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | 0.00% |
| Q3 2023 | 0.00% |
| Q2 2023 | 0.00% |
| Q1 2023 | -100.00% |
| Q4 2022 | 335.70% |
| Q3 2022 | -67.92% |
| Q2 2022 | 178.33% |
| Q1 2022 | -86.46% |
| Q4 2021 | 48.07% |
| Q3 2021 | 365.00% |
| Q2 2021 | -90.72% |
| Q1 2021 | 58.42% |
| Q4 2020 | -40.11% |
| Q3 2020 | 465.71% |
| Q2 2020 | -77.80% |
| Q1 2020 | 198.86% |
| Q4 2019 | -58.38% |
| Q3 2019 | 68.80% |
| Q2 2019 | -78.46% |
| Q1 2019 | 517.17% |
| Q4 2018 | -92.88% |
| Q3 2018 | 4833.31% |
| Q2 2018 | -67.47% |
| Q1 2018 | -74.92% |
| Q4 2017 | 51.50% |
| Q3 2017 | -55.15% |
| Q2 2017 | 244.21% |
| Q1 2017 | -67.50% |
| Q4 2016 | 173.82% |
| Q3 2016 | 169.22% |
| Q2 2016 | -60.14% |
| Q1 2016 | 80.54% |